Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Cohort Study to Evaluate the Safety and Efficacy of Pradaxa (Dabigatran Etexilate) for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery or Total Knee Replacement Surgery in a Routine Clinical Setting.

NCT00846807 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00846807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00846807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Cohort Study to Evaluate the Safety and Efficacy of Pradaxa (Dabigatran Etexilate) for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery or Total Knee Replacement Surgery in a Routine Clinical Setting.
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
February 28, 2009
Completion date
Not reported
Enrollment
5,476 (actual)
Sites
112

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, replacement, thromboembolism